sis (five year survival rate less than 5%). Some reports have demonstrated that external beam radiation therapy is effective in decreasing the size of unresectable carcinoma and may even be curative in patients having localized lesions. However the low radiation tolerance of surrounding structures often limits the external radiation dose. In this situation the application of radionuclides in the bile duct whether alone or in combination with external beam radiotherapy may be favourable in terms of significant palliation, local control and modest improve of survival. Up to now, for a transpapillary insertion only lowor medium dose-rate sources are practicable because of technical problems. On the other hand the presence of a transhepatic catheter allows the insertion also of high dose-rate sources into the bile duct system. During the last year we treated 8 patients with advanced carcinomas by means of the high dose-rate 192 Ir -afterloading system. No external beam radiation was applied because of widespread disease. The mean age of the patients was 60 years with a range of 33-79 years. A dose of 20-45 Gy in one to three sessions was delivered to a I cm radius. No severe side-effects related to irradiation could be observed. Four out of 8 patients are dead of disease 9,6,9 and 5 months from the date of first treatment. Up to now in most cases of interstitial radiotherapy of prostatic carcinoma a suprapubic implantation of 125 Iseeds has been made after lymphadeneetomy. Disadvantages of this method are the risk of an uneven seed distribution, the unequal emission of the seeds, the possibility of computing the dose distribution not before the application, the risk of loosing seeds and problems with radiation protection. For this reason we have developed a HDR -afterloading implantation method using 192 Ir-sources in cannelas. These cannelas are inserted from the perineum controlled by a transrectal ultrasound device. The advantages : no radiation exposure of the staff, short application times, possibility of positioning the needles exactly and prospectively and of fractionation, favourable combination with percutaneous radiotherapy. Extensive investigations of the radiotolerance of the rectum at HDR irradiation and excentric loading have been carried out using rats. HDR needs a stronger fractionstion because of a tolerance dose Factor of 2 compared to low-dose-rate. The new method has been applied at 15 male dogs. Dose and fractionation varied between lxlO Gy and 5xl5 Gy. The bladder and urethra dose has been measured with TLD rods and ionisation microchambers. Two rectum ulcers have been found at doses of 3x50 Gy and 5x15 Gy. Up to now we have treated 6 patients with prostatic carcinoma stage A and B in this way : 5 afterloading applications each 7,0 Gy and 50-35 Gy percutaneous radiotherapy. Using lumbar anaesthesia the acute tolerance has been excellent in all patients. The follow-up is 5-15 months. We have not found any bladder or rectum complications. Intracavitary brachytherapy will continue to play an important role in primary radiotherapy of gynecologic tumors. However, afterloading methods with remote control will more and more replace the classical radium therapy. The radiophysical and radiobiological differences between radiotherapy and afterloadingtherapy with remote controll are discussed and a comparison of both methods based on our own clinical results is presented. 
